Protective effects of taurine against MTX, gentamicin and carbamazepin's toxicity

Phase 2

Completed

• Conditions: Condition 1: Acute Lymphoblastic Leukemia. Condition 2: Infactious deases treated by gentamicin. Condition 3: Seizure.; Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue; Other bacterial diseases; Other disorders of the nervous system; C81-C96; A30-A49; G90-G99

• Registration Number: IRCT138812123482N1
• Lead Sponsor: Tabriz university of medical scienses

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

taking oral MTX or gentamicin or carbamazepin. Exclusion criteria: drug sensitivity, drug side effects, asthma, smoking, death.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified